Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full NewsRifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.
Hematology advanced nurse practitioners receive high satisfaction scores from clinicians and patients, although room for improvement remains regarding role clarity, a study reports.
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement.
Urinary tract infection during pregnancy is linked to an increased risk for preterm birth, with the risk being highest in the first week of diagnosis and particularly before 28 weeks of gestation.
A unique six-decade study shows that higher prenatal and early postnatal lead exposure is tied to cognitive performance in older adulthood.
NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.
Rates of the side effect appear to be increasing, but it’s not yet clear why.
1.
Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone
2.
Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer
3.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
4.
Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.
5.
A new way to measure suicide risk?
1.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
2.
Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength
3.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
4.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
5.
The latest research on Thyroid Cancer: Symptoms, Diagnosis, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
4.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge